European healthtech startups are transforming care delivery, diagnostics, and drug discovery. Strong public health systems create natural testing grounds, while regulatory clarity through CE marking and the MDR framework gives European companies a path to scale. We track 164 organisations in this sector across 6+ countries.
164 entries.
Deep-tech firm building AI-powered smart glasses that replicate guide-dog function for the visually impaired, using pedestrian autonomous-driving perception and haptic head-steering. Tested with 300+ blind users across ~30 countries.
Founded 2012 by 50 entrepreneurs. Accelerator offering hands-on mentorship and seed investment for tech, impact, and healthtech ventures; the mentor network includes founders behind BlaBlaCar, Le Bon Coin, and Showroomprivé. Support: equity investment, mentorship, Paris workspace. Scope: National.
A focused digital-health conference bringing pharma leaders, DTx specialists, regulators, and investors together around AI, real-world data, and patient-centric innovation. For digital-health founders it offers targeted access to pharma partners and regulatory expertise.
Ada Ventures is a London-based pre-seed and seed fund founded in 2019 by Check (Francesca) Warner MBE and Matt Bradley, focused on backing diverse founders building breakthrough technology across climate equity, economic empowerment, and healthy ageing. The firm closed its first fund at $50 million and raised a second fund of £63 million in March 2024, bringing total assets under management to over £100 million. Ada distinguishes itself as Europe's first VC fund explicitly designed to address underrepresentation in the startup ecosystem, investing £250K–£1M per company and running a scout and angel programme to surface talent overlooked by traditional networks.
Europe's largest cell and gene therapy event. Price: about GBP 2000; startups often access subsidized exhibition pods. Strong for biotech founders and manufacturing partners.
Invite-style AI & Data summit at Hotel Histria for 200 senior leaders across banking, telecom, healthcare, retail and public sector, with 50+ speakers focused on business value of enterprise AI.
Central Europe's largest AI conference, hosted at Magyar Zene Háza and Néprajzi Múzeum in Városliget. 12 sections and 100+ speakers cover AI across business, healthcare, employment, creative, and ethics.
Alan is a Paris-based health insurance and digital health platform founded in 2016 by Jean-Charles Samuelian-Werve (CEO) and Charles Gorintin (CTO) — the only new independent health insurer licensed in France since 1986. It combines group and individual health insurance with a mobile super-app offering reimbursements, telemedicine, mental-health support (Alan Clinic) and Mo, an AI health assistant delivering doctor-reviewed answers. By early 2026 Alan served over one million members across France, Belgium, Spain and Canada, with €785M ARR in 2025 (up 53%) and operational profitability in France. Alan has raised roughly €754M across eight rounds. It reached unicorn status in 2021 with a €185M Series D led by Coatue, and in March 2026 a €100M Series G led by Index Ventures — a backer since its Series A — valued the company at €5bn. Other investors include Temasek, Teachers' Venture Growth, Coatue, Lakestar, Partech, Belfius and DST Global.
Developed a proprietary biomaterial made from albumin — fully biocompatible and biodegradable — engineered for next-generation drug delivery and tissue engineering, with natural tumour tropism and built-in imaging visibility. Founded 2023.
Co-founder and CEO of Nabla, the clinical-AI assistant for clinicians. A repeat AI founder, he previously built VirtuOz and Wit.ai (acquired by Facebook) and led conversational-AI research at Meta.
Algalíf is an Icelandic biotechnology company founded in 2012 that produces high-grade natural astaxanthin from microalgae using 100% renewable geothermal energy in a fully enclosed indoor photobioreactor system. The company is certified carbon-negative, binding 75 tonnes of CO2 annually, and holds over $50M in cumulative investment. In 2025 Algalíf launched Astalíf 15, the world's first 15% natural astaxanthin oleoresin, and broke ground on the world's largest natural astaxanthin facility (12,500 m²). The board initiated IPO preparations for 2025 and appointed new leadership following the departure of long-serving CEO Orri Björnsson.
Accelerates cancer immunotherapy development with its HLA-Compass platform, a large quantitative database of HLA peptide presentation. AI-driven analytics predict off-target toxicity and support target discovery for safer, more precise therapies.
Germany's leading trade fair for nursing and elderly care services, attracting care providers, hospital managers, and technology vendors. Features exhibitions on care-tech, assistive robotics, and patient monitoring innovations. Day tickets cost about EUR 30. Particularly relevant for HealthTech and robotics startups targeting the aging population sector.
Amber Therapeutics is an Oxford-based bioelectronics medtech company developing next-generation implantable neuromodulation devices for pelvic and nervous system disorders such as overactive bladder. Spun out from the University of Oxford, the company combines advanced microelectronics with closed-loop stimulation algorithms that adapt treatment in real time based on patient physiology. Amber has raised funding from deep-tech and life-science investors to advance its platform through clinical development. The company represents a growing wave of UK-based bioelectronic medicine startups tackling chronic conditions with precision device therapies.
Aptamedica is a Warsaw-based medtech startup developing a real-time, point-of-care therapeutic drug monitoring platform for intensive and critical care. Its core product, AptaSense, is a bedside analyzer that uses single-use, aptamer-based (DNA biosensor) test strips to measure blood concentrations of antibiotics such as vancomycin, gentamicin and amikacin, plus the sepsis biomarker procalcitonin, returning results in roughly one minute from a venous sample — removing the need to send samples to a central lab and enabling immediate, precise dosing. The platform extends beyond the handheld analyzer: AptaFlow integrates into haemodialysis circuits for continuous real-time drug monitoring, while AptaSoft is an AI-assisted dosing tool aimed at neonatal care. New analytes such as troponin and digoxin are in the development pipeline and can be added via software. Founded by Maciej Łach, Mateusz Fil and Kamil Pawełkiewicz, the company is at prototype stage and has taken part in Polish innovation programmes including Warsaw Booster and the Mother and Child Startup Challenge; no external funding round has been publicly disclosed to date.
Aqemia is a Paris-based pharmatech company building an AI-driven drug discovery platform that combines quantum-inspired physics and machine learning to generate and prioritise novel drug candidates at scale. Founded in 2019 by quantum physics researcher Maximilien Levesque and former BCG consultant Emmanuelle Martiano, the company aims to design new molecules faster and cheaper than traditional methods. It raised a 60M euro Series A and later a $38M round led by Cathay Innovation in December 2024, bringing total funding past $100 million as it moves toward clinical trials and global expansion, including a London office.
Develops a patented near-infrared fluorescent coating (NICE) for surgical instruments, letting surgeons visualise tools inside the body during minimally invasive procedures. Spun out of Strasbourg's Laboratory of Bioimaging and Pathologies.
Develops Semi-Permeable Capsule and droplet microfluidics partitioning technology enabling multi-step, multi-omic single-cell analysis workflows for research and high-throughput screening.
Life sciences partnering conference in Lisbon built around structured 1:1 meetings between biotech startups, pharma companies, and investors. Registration costs about EUR 2800+. Covers drug discovery, clinical development, and licensing. Essential for biotech startups seeking licensing deals, co-development partnerships, and Series A+ funding from specialized life-science investors.
Europe's leading partnering event for early-stage life-sciences innovation and technology transfer, in its 15th edition at Parc Chanot in Marseille. Built around one-on-one partnering meetings, it is ideal for biotech and medtech founders seeking licensing deals, academic collaborations, and early investors.
BioInnovation Institute is a life science incubator backed by the Novo Nordisk Foundation that helps researchers and founders turn biotech and health innovations into venture ready companies. Based in Copenhagen, BII provides lab space, grant funding, expert business support, and access to investors for projects in therapeutics, diagnostics, and industrial biotech. It runs programs for both idea stage research and early startups, de risking science heavy ventures before they seek larger capital. BII is a central node in the Danish life science startup pipeline.
One of Europe's largest biotech partnering events, in its 13th edition and run by industry association AseBio, known for its high volume of one-to-one investor and company meetings. Essential for biotech and life-sciences founders raising capital or seeking pharma and research partners.
Built around the Cambridge deep-tech cluster, with a 2026 theme of how deep tech changes the world. It features an Innovation Alley exhibition for deeptech startups and scaleups, plus sessions on scaling, regulation, and access to capital — high value for science-led founders seeking investors and corporate partners.
Cardiomatics develops cloud-based AI software that automates reading and interpretation of electrocardiograms (ECG), detecting ~20 heart abnormalities and generating diagnostic reports in minutes. It received European medical-device certification in 2018 and has analysed millions of hours of ECG signals for 700+ customers across 10+ countries.
Clinical Trials Information Network, founded in 2023 and headquartered in Warsaw, operates ClinicalTrials.eu, a patient-focused platform that makes clinical trial information across Europe more accessible. It aggregates publicly available data from international trial registries, academic centres, national regulators and commercial sponsors, letting users search trials by disease, drug name or location and access structured patient materials.
Corti is a Copenhagen-based AI company founded in 2016 that initially gained recognition for building real-time AI assistants for emergency call centers, helping dispatchers detect cardiac arrests and other critical conditions during 112/911 calls. The company has since expanded into broader healthcare AI infrastructure, providing clinical documentation, medical coding, and workflow automation tools for hospitals and health systems. Corti's models are trained on millions of patient interactions and support clinicians in making faster, more accurate decisions. The company is one of Denmark's most prominent healthcare AI startups.
CurifyLabs is a Helsinki-based HealthTech company automating the production of personalised medicines. Its Compounding System Solution combines proprietary software, GMP-manufactured excipient bases, and 3D-printing hardware (including the PharmaPrinter Aurum) to let pharmacies compound and dispense custom-dosed medications up to nine times faster than manual methods. Founded in 2021 by Charlotta Topelius and Niklas Sandler — a professor of pharmaceutical technology at Åbo Akademi University with over a decade researching automated compounding — the company's technology is already in use across pharmacies in 21 U.S. states and multiple European countries. In July 2026, CurifyLabs closed a $14 million Series A, co-led by Sandwater and HealthCap with participation from Tesi (Finnish Industry Investment Ltd.) and existing investor Lifeline Ventures, to expand its compounding platform.
Dawn Health develops regulated software-as-a-medical-device products with pharmaceutical and life-science partners. The company builds digital therapeutics and companion applications for adherence, remote monitoring, and real-world clinical data capture in regulated settings.
AI-powered digital pathology company pairing artificial intelligence with a global network of expert pathologists. Its Diagnexia (clinical) and Patholytix (preclinical) platforms speed diagnosis and ease the pathologist shortage. Founded 2017.
Co-founder and COO of Nabla, leading operations and partnerships for the clinical-documentation AI company used by thousands of practitioners.
Founded in 1994, Delta Partners is one of Ireland's longest-running venture capital firms, investing EUR 0.5-3M at seed and Series A in enterprise software and consumer technology across Ireland and the UK. The firm manages over EUR 300M across multiple funds backed by Enterprise Ireland and private LPs. Delta has backed 90+ companies including Movidius (acquired by Intel), CurrencyFair, and Luzern. The team focuses on capital-efficient B2B and consumer startups with international scaling potential.
Distalmotion develops Dexter, a hybrid robotic surgery platform intended to make robotic-assisted minimally invasive procedures more accessible to a broader hospital base. The system allows surgeons to move between robotic and laparoscopic workflows during operations to improve flexibility and operating-room integration.
Organizer of DMEA, Europe's leading digital health and healthcare IT trade fair held annually in Berlin. Drawing over 16,000 attendees and 700 exhibitors, DMEA showcases innovations in electronic health records, telemedicine, AI diagnostics, and hospital IT infrastructure, serving as a key meeting point for healthtech startups and health system leaders.
Europe's largest digital health trade fair at Messe Berlin, spanning healthcare IT, procurement, interoperability, and compliant medical software rollout. Includes the 'DMEA fuer Health Startups' program, the DMEA nova Award startup finals, and DMEA Sparks pitch visibility for early-stage health-tech companies.
DocPlanner is a Polish-founded healthcare booking and patient engagement platform operating brands such as ZnanyLekarz and MioDottore. The group expanded across Europe and Latin America and in 2017 acquired Germany’s Jameda, strengthening its presence in the DACH market; its TuoTempo brand deepened the practice management stack for larger healthcare providers. DocPlanner is backed by investors including Point Nine Capital, Goldman Sachs Private Capital, and One Peak Partners. The company connects patients with doctors while offering clinics scheduling, CRM, and telehealth tools.
Doctena is a Luxembourg-based healthtech platform that enables patients to book medical appointments online across multiple European countries. The system connects patients with doctors, dentists, and specialists through a unified booking interface while providing healthcare practitioners with schedule management, patient communication, and practice administration tools. Operating across Luxembourg, Belgium, the Netherlands, Germany, and Austria, Doctena has become one of the leading medical appointment platforms in the Benelux region and a key example of how healthtech can scale across fragmented European healthcare systems.
Doctolib was founded in 2013 in Paris and operates Europe's largest digital healthcare platform, enabling patients to book medical appointments online and access telemedicine services across France, Germany, and Italy. The company reached unicorn status in 2019 with a €150 million Series D led by General Atlantic, and raised a further €500 million in 2022 at a €5.8 billion valuation. It serves tens of millions of patients and hundreds of thousands of healthcare professionals, making it one of the most widely used health platforms on the continent.
Digital-first primary care and patient-doctor relationship platform that lets private physicians run long-term care programmes with patients through async messaging, visits, and care plans. Positioned as an alternative to transactional telemedicine, with a subscription model aligning doctor and patient incentives. Backed by Movens Capital.
VIB-linked biotech developing Treg-based immune modulators for hard-to-treat autoimmune diseases. Lead program DT-001 is a TNFR2 antibody agonist in IND-enabling studies. Founded 2020; raised EUR 40M Series A in 2023.
EBO is a Malta-founded conversational and generative AI company specialising in automated customer engagement for regulated industries. Founded in 2017 by Dr. Gege Gatt, the platform deploys multilingual Virtual Agents across healthcare, financial services, telecommunications, and iGaming, operating in over 100 languages and delivering 24/7 automated dialogue across any channel. EBO's clients report over 80% reduction in customer interaction costs. The company has raised $3.5 million, counts BMIT Technologies among its investors, and operates from Birkirkara with additional offices in London and Milan.
Specialist cardiology congress in Paris focused on heart rhythm disorders, arrhythmia management, and electrophysiology innovation. Attracts 5,000+ clinicians, device manufacturers, and researchers. Registration costs about EUR 600-1000. Particularly relevant for ECG AI, cardiac monitoring, and implantable device startups seeking clinical validation and distribution partners.
Eight Roads Ventures is the global venture capital platform of Fidelity, tracing its roots to Fidelity Ventures (1969). Headquartered in London for its European and Israeli operations, it invests exclusively from Fidelity's balance sheet rather than raising external LPs — a structure that affords long holding horizons. The European arm has deployed four successive funds, growing from £100M to a $450M fourth fund (2021), within a global platform managing over $5bn across Europe, Israel, India and Asia. The London team focuses on growth-stage and scale-up investments, writing $5–50M cheques into companies past product-market fit (roughly Series A–C) in SaaS and enterprise software, fintech, healthtech, consumer technology and climate tech. Notable European portfolio companies include Spendesk (France), Hibob (Israel/UK), Funnel.io (Sweden), Tibber (Norway), Swan (France) and Amenitiz (Spain); key exits include InnoGames (€260M to MTG, 2016), Compte-Nickel (BNP Paribas, ~€200M, 2017) and Made.com's 2021 London IPO. The team is led by Managing Partner Davor Hebel with partners Lucile Cornet and Michael Treskow.
EIT Digital Accelerator is a pan-European programme backed by the EU's European Institute of Innovation and Technology (EIT), supporting deep tech scaleups with tailored business development, investor introductions, and international customer acquisition since 2012. It operates across 18 European cities and a San Francisco hub, and has supported nearly 300 startups that collectively raised €1.5 billion, with over €100 million directly facilitated by the Accelerator. Focus areas include AI, cybersecurity, digital industry, digital health, and fintech.
EPFL (École Polytechnique Fédérale de Lausanne) is Switzerland's second federal technical university, situated on the shores of Lake Geneva. Ranked among Europe's top research universities, EPFL has become one of the continent's most prolific generators of deep-tech and life-sciences startups, producing over 400 spin-off companies since 2000. Notable alumni companies include Nexthink, SOPHiA GENETICS, Astrocast, and Distalmotion. EPFL Innovation Park, located adjacent to the main campus, houses hundreds of startups and bridges academic research with commercial application across quantum photonics, precision health, robotics, and digital finance. The park includes an ESA BIC Switzerland programme that incubates space-tech startups. For founders in the Lake Geneva region, EPFL provides a uniquely dense combination of technical research infrastructure, institutional support, venture-ready talent, and direct access to EPFL's technology transfer office.
Global congress for clinical microbiology and infectious diseases at Messe Munich, drawing 15,000+ clinicians, researchers, and industry buyers from 130+ countries. Registration about EUR 600-900. Ideal for diagnostics, AMR, and medtech startups with clinical data seeking KOL validation, hospital pilots, and pharma partnerships.
A week-long showcase of Estonia's e-health, healthtech, and biotech ecosystem, opening in Tallinn and moving to Tartu, and including the DTx New Nordics Conference. Free to attend, designed for healthtech entrepreneurs, startups, clinicians, and investors.
Summit at the Mediterranean Conference Centre with 2,500+ attendees and 400+ investors. Features the Big Pitch Competition with a prize package worth over EUR 1M and strong media visibility.
Clinical-stage biotech developing therapeutics for neuropsychiatric disorders. Lead program Deraphan targets agitation and aggression in Alzheimer's disease dementia and is in Phase 2/3. Raised EUR 51M Series B in 2026.
A Radboudumc spin-off developing a patented AR projector that overlays anatomical data — blood vessels, muscles, nerves — directly onto a patient's skin during surgery, without screens or headsets. Used in 400+ surgeries.
World's largest fitness and wellness trade show, held in Cologne with 150,000+ visitors and 1,100+ exhibitors. Covers wearables, health tracking, connected gym equipment, and sports nutrition innovation. Day tickets cost about EUR 40-90. Highly relevant for HealthTech and wearable startups targeting the fitness industry.
FIRE1 is a Dublin-based medtech company developing the NORM heart failure management system, a remote monitoring implant designed to enable patients to control their fluid volume at home, similar to how continuous glucose monitors transformed diabetes care. The device received FDA Breakthrough Device Designation and has been successfully implanted in the first Irish patient at University Hospital Galway. FIRE1 has raised $210 million in total funding, including a $120 million round led by Polaris Partners and Elevage Medical Technologies.
Flo Health is the world's most popular women's health app, offering AI-powered period and ovulation tracking, pregnancy monitoring, and personalized health insights to over 300 million users. The company combines reproductive health data with machine learning to provide tailored content and predictions, and has expanded into telehealth and wellness features. Flo represents a major European consumer health success story.
A two-day summit at the Dublin Royal Convention Centre joining clinicians, hospital managers, pharma, health-tech firms, and policy people. Relevant for digital-health and medtech founders seeking healthcare buyers and partners.
GenePlanet was founded in 2008 by Marko Bitenc and Nina Šterk and is the leading European provider of preventive genetic tests, including non-invasive prenatal testing (NIPT), cancer screening, and lifestyle DNA tests. The company cooperates with more than 500 clinics, hospitals, and insurance firms worldwide and markets its products under brands including NutriFit. In July 2023 GenePlanet closed a €20 million Series B round led by BlackPeak Capital, bringing total funding to approximately $34 million. It was ranked among the 1,000 fastest-growing companies in Europe by the Financial Times.
La Famiglia is a European seed-stage venture capital firm founded in 2016 by Jeannette zu Fuerstenberg, with offices in Berlin, Paris, and London. The firm bridges the gap between European industry corporates and technology startups, leveraging a network of 200+ family-owned enterprises as LPs and advisors. La Famiglia invests EUR 500K to EUR 3M at pre-seed and seed in B2B SaaS, fintech, and marketplace models. Notable portfolio companies include Personio, Solarisbank, Forto, and Pile Capital. The firm manages over EUR 250M and provides unique access to industrial pilot customers and distribution channels.
The 26th edition of One Nucleus's flagship London life-science networking conference, themed around maximising returns from life-science innovation. For a biotech or life-science founder it is a focused day of partnering and investor networking within the UK life-sciences cluster.
A biennial gathering at Campus Biotech, one of the largest global health conferences, bringing political, private, academic, and civil-society actors together on global health innovation and policy. For a healthtech founder in the Romandie it is the marquee venue to reach NGOs, multilateral health bodies, and impact funders.
GESDA Summit convenes 1,000+ scientists, diplomats, policymakers and innovators at Palexpo Geneva to translate anticipated scientific breakthroughs across quantum, neurotech, AI, climate and global health into actionable coalitions and governance.
Invitation-only Clinical Accelerator summit on cardiovascular and interventional medical devices, gathering physicians, medtech founders, and investors. Includes a Shark Tank pitch competition with a $25,000 prize for early-stage MedTech startups.
A two-day NHS innovation festival with six distinct shows under one roof and hundreds of speakers at the Business Design Centre, London. For a healthtech founder it offers concentrated access to NHS leaders, clinicians, and health investors — useful for validation, partnerships, and early traction.
Luxembourg-based social-impact startup using AI and positive psychology to build youth mental resilience. Its tools are designed for schools, families, and public health agencies to provide preventive mental-health education for children. Named among the Global Top 30 AI Impact Solutions at the AI Impact Summit 2026. Founded by Luanna Eroles.
Billed as Southern Europe's largest digital health congress, drawing 3,000+ attendees and around 450 companies to the Recinte Modernista de Sant Pau. For healthtech founders it is a concentrated dealmaking venue with keynote stages, a startup exhibition, and direct access to hospitals, pharma, and investors active in digital health.
Cross-border healthcare conference and trade show organised by the Federation of Luxembourg Hospitals at Luxexpo The Box. Brings together hospital leaders, IT and HR directors, healthtech startups and researchers around digital health, innovation and patient experience.
Virtual matchmaking event connecting healthtech startups with healthcare providers, hospitals, and investors across the Nordic region. Features structured 1:1 meetings and pitch sessions focused on digital health, medtech, and care delivery innovation. Valuable for health-tech startups seeking clinical pilot partnerships and Nordic market entry.
Hedepy is an online therapy platform connecting patients with certified psychotherapists via video. It has expanded across more than ten European markets, offering multilingual access and flexible scheduling. The service addresses mental health capacity shortages by making therapy easier to access and scale. By 2026, Hedepy is a leading Czech health-tech company in digital mental health.
Hemab is a clinical-stage biotech company developing prophylactic therapies for severe bleeding and thrombotic disorders. Founded by biotech operators with Novo Nordisk roots, the company engineers antibody-based treatments aimed at preventing episodes before they occur in underserved rare-disease populations.
The UK's leading digital-health conference and exhibition, bringing NHS leaders, policymakers, clinicians, and tech companies together at ExCeL London. For a healthtech founder it is the key venue to understand NHS procurement, demo to buyers, and meet partners driving digital transformation in care.
Organizer of HLTH Europe, a major health innovation conference connecting digital health startups with healthcare decision-makers in Amsterdam. Launched as the European sister event of the US-based HLTH conference, it brings together thousands of healthtech founders, hospital administrators, and investors to drive digital transformation in healthcare.
Pan-European health innovation conference at RAI Amsterdam connecting providers, payers, pharma, policymakers, and digital health startups. Strong entry point for navigating fragmented national healthcare systems through centralized buyer and partner access.
Holi, founded in 2023 and headquartered in Warsaw, is a digital metabolic wellness clinic focused on obesity treatment and long-term weight management. It combines medical supervision, GLP-1-based pharmacotherapy where appropriate and behavioural support delivered through an integrated app, with care from physicians and psycho-dietitians, ePrescriptions and measurement tracking. Holi reports more than 2,500 patients served.
HomeDoctor is a Polish digital-health platform offering telemedicine consultations and in-home doctor visits across 30+ specialties. It runs a B2B model partnering with medical centres, insurers and employers to provide healthcare as a corporate benefit, with 200+ doctors serving patients nationwide.
Information day on funding opportunities for health-related projects under the Horizon Europe framework programme, specifically for Cluster 1 (Health). Provides guidance for applicants and consortia.
Idoven is a Madrid-based digital health startup that uses AI to transform ECG analysis and cardiovascular diagnostics. Its Willem™ platform analyses 50,000 heartbeats in 60 seconds, identifying 86 electrical heart conditions that represent 90% of common cardiac problems — reaching 96.4% accuracy for atrial fibrillation detection. Founded in 2019 by Manuel Marina Breysse, José María Lillo Castellano, and Íñigo Juantegui, the company raised €18.5M Series A co-led by Insight Partners and Northzone with Wayra participation. Idoven operates B2B through hospitals, pharmaceutical trials, and healthcare systems, and employs 71 people as of early 2026.
Health AI company building medical guidance and triage tools for providers, insurers, and digital health platforms. Its platform automates symptom assessment and patient routing in multiple languages across international markets.
Warsaw-based AI biotech founded in 2023 by the team behind Applica (acquired by Snowflake), building a Biological Reasoning Engine that fuses multimodal biological data to accelerate oncology drug discovery. Raised €13M led by Sofinnova Partners.
Spanish entrepreneur and investor who co-founded the digital road-freight marketplace OnTruck and is also a co-founder of the AI cardiology startup Idoven. He is an active figure in the Madrid startup ecosystem across logistics and health tech.
Founded 2002. Academic incubator supported by University of Vienna, TU Wien, and Vienna Business Agency. Helps research-driven startups commercialize IP via START:IP and SCALEup, with funding up to EUR 100K and lab access. Scope: Regional (Vienna).
Inovo Venture Partners is Warsaw-based and one of Poland's leading seed-stage venture firms, backing technology founders from Central and Eastern Europe building for global markets. Founded in 2014 with a €8M Fund I, Inovo has scaled to roughly €167M across three funds: Fund II (€54M, 2021) and Fund III (€105M, 2023), the latter backed by IFC, the European Investment Fund and PFR Ventures alongside private LPs including InPost founder Rafał Brzoska and Snowflake co-founder Marcin Żukowski. The firm writes €0.5–4M initial tickets at pre-seed and seed, with follow-on capacity up to €10M. Inovo concentrates around 60% of each fund in Poland and the remainder across CEE — with investments in Croatia, Lithuania, Serbia, Ukraine, Slovakia and Romania — and opened a Balkans hub in Skopje in 2024. It is generalist within technology but has particular conviction in AI, developer tools, digital health, SaaS and B2B software. The portfolio spans more than 55 companies, including Booksy, Tidio, Spacelift, Infermedica, Preply, Packhelp and AI Clearing. Notable outcomes include the Warsaw Stock Exchange IPOs of Brand24 and ECC Games and the acquisition of SplxAI by Zscaler in 2025, one of the largest CEE AI exits to date.
Norwegian medical doctor, PhD, and Associate Professor in artificial intelligence at the University of Agder, and one of Norway's most prominent voices on AI in healthcare and society. Author of a book on AI in medicine, she is a confirmed speaker at the Y Oslo 2026 conference.
Co-founder of Doctolib, part of the founding team that built the medical-booking platform into a European health-tech leader alongside CEO Stanislas Niox-Chateau.
Develops patent-pending faecal management briefs that contain stool in a disposable pouch immediately after excretion, cutting stool-to-skin contact and care-change time. Founded after the founder lost his father to pancreatic cancer. Targets care homes, hospitals and domiciliary care.
Jutro Medical is a Warsaw-based, AI-first primary care operator that integrates online and offline care. Founded in 2020, it has grown from a single tech-enabled clinic into an integrated operator running around 20 clinics across Poland and serving roughly 120,000 patients. The company embeds AI agents directly into clinical workflows to handle patient intake and documentation, freeing doctors for clinical decisions.
Angel investor and board member at COBIN Angels, Kasia is based in Switzerland and helps connect Swiss and Polish startup ecosystems. She is vice-president of the Swiss-Polish Blockchain Association and brings specialization in health economics. Her portfolio and advisory focus include Bitfold and early-stage teams using blockchain in healthcare data management and security.
Kilo Health is a Vilnius-based digital health company founded in 2013 that builds, acquires, and scales a portfolio of 30+ health and wellness apps spanning weight management, fitness, mental health, chronic disease management, and personal care. The company serves over 7 million paying customers globally and employs 500+ people across Lithuania, Germany, and Latvia. Kilo Health operates as a health-app studio, applying performance marketing expertise and data-driven product iteration to grow individual apps rapidly. It is one of the largest and most profitable digital health companies in the Baltics, demonstrating Lithuania's strength in consumer app businesses.
Kry is a Stockholm-based digital healthcare company founded in 2014 that connects patients with doctors, nurses and psychologists through video and app-based consultations, and also runs physical clinics in some markets. Known as Livi outside the Nordics, it operates in Sweden, Norway, France, Germany and the United Kingdom and became one of Europe's most funded digital health companies.
LetsGetChecked is a Dublin-founded at-home diagnostics and virtual care company that ships regulated lab tests directly to consumers, processes samples through its own CLIA-certified laboratories, and wraps the results in physician review, prescribing, and follow-up care where appropriate. Founded in 2015 by Peter Foley, the company rode the pandemic-era shift toward home testing to a USD 1 billion Series D in 2021 and has since positioned itself as a full virtual-care platform covering sexual health, men's and women's health, wellness, colorectal screening, and medication adherence, selling both direct-to-consumer and as a corporate health benefit. It is one of the few European health-tech unicorns to successfully run end-to-end clinical infrastructure — labs, logistics, telehealth, and pharmacy — in the US market, and together with Kerecis and Sidekick Health it rounds out the directory's picture of how Irish and Icelandic health companies are building internationally regulated care businesses.
One-day life sciences convention in Heidelberg featuring biotech keynotes, startup pitch competitions, and investor panels. Organized by BioRN, the Rhine-Neckar biotech cluster, and attended by pharma executives, academic researchers, and VCs. Strong entry point for early-stage biotech and medtech founders seeking funding and strategic partnerships.
Lightrock is an impact-focused growth equity platform backed by LGT Group, the private banking and asset management group owned by the Princely House of Liechtenstein. Founded in 2019 as a spin-out from LGT's direct private equity activities, Lightrock deploys growth equity tickets of €10–50M into companies demonstrating measurable positive impact across climate, health, and financial inclusion. The firm operates from London with offices in Basel, New Delhi, São Paulo, and other cities, giving it an unusually broad emerging-market reach alongside its European portfolio. Notable portfolio companies include Bima, Karma Kitchen, and Proxona. Lightrock occupies a distinctive position in European impact investing: it combines the balance sheet credibility of a century-old royal banking group with a focused mandate, operational on-the-ground presence, and a willingness to invest in geographies and sectors that conventional growth equity skips. For Swiss and European founders building in healthcare access, climate solutions, or financial inclusion, Lightrock is one of the few growth-stage investors that evaluates impact metrics alongside financial ones.
Lindus Health is a UK-founded clinical-trials company that brands itself as the anti-CRO, offering an end-to-end, technology-enabled alternative to traditional contract research organisations. It combines a proprietary AI-assisted trial operating system (Citrus) with in-house medical and clinical staff to handle protocol design, patient recruitment, data collection, biostatistics, and regulatory compliance. The platform draws on electronic health records to identify and enroll patients faster, and the company contracts on milestone-based commercial terms. Founded in 2021, it runs trials across therapeutic areas and operates across the US, UK, and Europe.
Government-backed UK flagship tech week at Olympia with 45,000+ attendees, 5,000+ startups, and 300+ investors across AI, quantum, fintech, and health tech. Main-stage passes typically GBP 600-1,500 with free fringe events. Founder tracks, UK policy programming, and EQL:HER make it a key entry point for founders targeting UK enterprise buyers.
YC-backed preventive health platform that analyses 110+ blood biomarkers with AI to deliver personalised, physician-reviewed guidance on nutrition, supplementation and lifestyle. Operates across France, the UK, Ireland and Portugal with 10,000+ users since its 2025 launch.
Investment Director at Movens Capital. Drives sourcing and execution across fintech, edtech, and healthtech opportunities in Poland and the broader CEE region; previously in product and operating roles in tech-enabled services.
Partner at Movens Capital. Investment professional focused on CEE early-stage tech, with deal experience across SaaS, fintech, and digital health. Works with founders on go-to-market, fundraising strategy, and cross-border expansion from Poland into Western Europe and the US.
European curated dealflow event at Luxexpo The Box, hosting ~3,400 attendees, 330+ investors and the Fit 4 Start and Fit 4 Scale closing pitches. Connects high-potential startups and scaleups with VCs, family offices and angels across digital, healthtech and space.
Angel investor and host of the Zaprojektuj Swoje Życie podcast, Maciej is known as one of Poland’s most transparent private investors, openly sharing portfolio wins and failures. With prior senior leadership roles at Dell and NTT, he focuses on stable B2B SaaS models and healthtech opportunities. His publicly discussed portfolio includes Just Join IT, Booksy, and HiPeople.
Medical device company commercializing ReActiv8, an implantable restorative neurostimulation system that treats disabling mechanical chronic low back pain by stimulating the lumbar multifidus muscle. HQ in Dublin.
Poland's first digital platform dedicated to supporting women through the menopausal transition, offering a knowledge base, symptom monitoring and personalised programs spanning diet, exercise and specialist access on a freemium model.
Founder of Coders Lab (one of the first Polish coding bootcamps), Marcin has since become an angel, especially in edtech and health startups. He has invested in companies like Tomorrow Medical and Listny Cud, while also serving as a mentor in programs like PFR School of Pioneers. Associated startups: Tomorrow Medical, Listny Cud (Leafy Miracle), and other edtech/healthtech startups.
A veteran of Poland’s startup scene, Mariusz founded GoldenLine and DocPlanner. Alongside running a unicorn-scale company (DocPlanner), he has been an angel in numerous startups including Preply, Shoplo, Positionly, and Brainly. He often provides both capital and guidance on scaling to international markets. Associated startups: Preply, Shoplo, Positionly, Brainly, Allani, among others.
Materialise is a pioneer in additive manufacturing, operating one of the world's largest 3D printing facilities alongside a suite of industrial and medical software. Its Mimics software suite supports surgical planning, personalised implants and medical device design for hospitals and MedTech firms globally; its industrial arm serves aerospace, automotive and consumer goods. Founded in 1990 in Leuven by Fried Vancraen and Hilde Ingelaere as the Benelux's first rapid-prototyping bureau, the company listed on NASDAQ (MTLS) in 2014. As of Q1 2026 it reported $302 M trailing revenue and a $335 M market cap, and in May 2026 spun off its eyewear division to focus on core manufacturing and healthcare software.
Robotic microsurgery company behind the Symani Surgical System, pairing the world's smallest wristed NanoWrist instruments with tremor reduction and motion scaling for open soft-tissue microsurgery. FDA clearance 2024.
Ninth edition of Europe's second-largest medical device design and manufacturing show at Galway Racecourse. Features a conference programme, Women in MedTech Forum and German Pavilion across 300+ MedTech companies in Ireland's MedTech capital.
Warsaw Stock Exchange–listed remote cardiac diagnostics company. Its PocketECG platform combines a mobile ECG device with AI-assisted arrhythmia detection and a 24/7 diagnostic service used by clinics and providers in the US, Europe, and Asia. An early Movens Capital portfolio company (IPO exit).
Flagship European medtech gathering at the Mediterranean Conference Centre with 2,000+ delegates across two stages, connecting health-tech startups with investors, clinicians, and regulators. Strong startup pitch and investor matchmaking tracks.
Warsaw-based multi-stage venture capital firm backing Central and Eastern European tech founders with global ambitions. Movens Capital runs a €60M Fund 2 (launched 2025) and writes first checks of €250k–€3M at pre-seed through Series A+. Focus areas: fintech, edtech, healthtech, deep tech, climate tech, enterprise software, and e-commerce enablement across Poland, the Baltics, the Balkans, Czechia, Slovakia, Hungary, Romania, Ukraine, and Moldova. Founded in 2018 by Artur Banach and Michał Olszewski. Fund LPs include the European Bank for Reconstruction and Development (EBRD), PFR Ventures, and 80+ tech founders, operators, and family offices. Notable exits include MEDICAlgorithmics (IPO) and Fenige.
Develops MSIcare, bioinformatics software that analyses microsatellite instability biomarkers from next-generation sequencing data to guide oncologists in selecting targeted immunotherapy across cancer types. Winner of France's i-Lab 2023.
Paris-based clinical AI company that listens to doctor-patient consultations in real time and auto-generates structured medical notes, referral letters, and billing codes. Used by thousands of clinicians across France, the US, and Canada, reducing documentation time by over 50%.
NanoSci is a Warsaw-registered Polish deep-tech startup, founded in 2020, that develops photocatalytic air-purification technology licensed to manufacturers of ventilation, lighting and transport equipment. Its core IP — researched at the University of Gdańsk under Prof. Adriana Zaleska-Medynska — is built on porous titanium dioxide (TiO₂) nanolayers and nanotube arrays activated by UV-LED light. The photocatalytic reaction generates hydroxyl radicals that continuously decompose volatile organic compounds, nitrogen oxides, odours, bacteria, viruses and fungi into harmless CO₂ and water vapour, with no replaceable filters and very low energy use. Rather than selling finished consumer devices, NanoSci provides modular photocatalytic engines to OEM and white-label partners; an early collaboration with bus maker Solaris demonstrated the technology in public-transport air conditioning. Two branded lines are now visible: Jupitair, targeting food and greenhouse environments (with deployments in Singapore and the Philippines and a place in Thailand's SPACE-F accelerator), and Airchanger, a decentralised heat-recovery ventilation unit with integrated purification. The company has raised early equity alongside Polish state grants and support from accelerators including AcceliCITY and Estonia's Beamline.
Natural Cycles is a Stockholm-based femtech company founded in 2013 that makes a fertility-awareness app which uses body-temperature data and an algorithm to identify fertile and non-fertile days. It became the first app cleared by the US FDA to be marketed as a form of contraception and also supports users planning pregnancy.
Neko Health is a Stockholm-based preventive health company co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek (the Spotify founder). Neko operates clinics that offer AI-powered full-body health scans using proprietary sensors and imaging technology to detect early signs of cardiovascular disease, skin cancer, diabetes, and other conditions. A scan takes about 15 minutes and costs a fraction of traditional medical imaging. The company has raised over $260 million, including a $260 million round in 2024, and is expanding its clinic network across Sweden and the UK. Neko Health represents a new model of proactive, technology-driven healthcare that could reshape how Europeans approach preventive medicine.
Neurent Medical is a Galway-based medtech company developing the NEUROMARK device, which uses proprietary Impedance Controlled Radiofrequency technology to target overactive posterior nasal nerves and treat chronic rhinitis — a condition affecting over 500 million people globally. Founded in 2015, the company closed an oversubscribed €62.5 million Series C in February 2026, led by MVM Partners with participation from Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, and Enterprise Ireland, bringing total funding to over €100 million.
Polish-Israeli medtech startup developing VGuard, a non-invasive vagus nerve stimulation system aimed at improving cognitive outcomes in patients with Alzheimer’s disease and dementia. The company is advancing clinical validation and regulatory pathways across Europe and the US.
Medical-device company developing bimodal neuromodulation technology. Its flagship product Lenire is the first FDA-approved bimodal neuromodulation tinnitus treatment, available in 130+ clinics across the US and Europe. Founded 2010.
Nightingale Health is the global leader in NMR-based metabolomics, quantifying 250 blood biomarkers from a single sample to enable large-scale disease risk detection and prevention. Founded in Helsinki, it completed the analysis of all 500,000 UK Biobank samples, creating the world's largest blood biomarker database. Listed on Nasdaq Helsinki Main Market since March 2025, the company is deploying its technology into Finnish public healthcare in 2026 through wellbeing services counties. It also partnered with Alamar Biosciences to expand into brain health proteomics.
No Isolation is a Norwegian scale-up founded in 2015 that develops telepresence robots to combat social isolation. Its flagship product, the AV1 robot, serves as a physical avatar in classrooms for children with long-term illness or special education needs, keeping them connected to school and peers when they cannot attend. The company now serves over 900 customers across 19 countries with more than 3,000 AV1 units deployed in around 2,500 schools, supporting over 10,000 children. No Isolation won the 2025 EURORDIS Company Award for Health Technology.
Nobi makes AI-powered smart ceiling lamps for senior living facilities that detect falls within seconds, alert caregivers instantly and monitor sleep, activity and circadian patterns to prevent incidents. Its model was trained on 250,000+ real-life fall scenarios; in clinical studies across five care homes, Nobi reduced average caregiver response time from over one hour to four minutes and cut falls by 51%. Founded in 2018 in Antwerp by Roeland Pelgrims, Bert De Haes and Stijn Verrept, it closed a €35 M Series B (co-led by Angelini Ventures and Nexus NeuroTech) in January 2025. Nobi is deployed in 22 countries with offices in Belgium, the US and the UK.
The premier Nordic life-science partnering event organised by SwedenBIO, rotating to Stockholm in 2026. Brings biotech, pharma, medtech, and digital-health players together for partnering meetings, panels, and company presentations.
Nucleus Ventures is a venture building and corporate innovation advisory firm based in Cyprus, founded in 2014. It offers services including venture building, fundraising, soft-landing support for international market entry, operational advisory, and capacity building programmes. The firm serves governments, corporations, and founders across the EMENA region, with particular experience in FinTech, HealthTech, and AI. Nucleus Ventures has also managed government-backed accelerator and seed fund programmes.
Molecular diagnostics company developing next-generation sequencing assays and software for HLA typing in transplantation, including the Holotype HLA and NanoTYPE systems for clinical labs.
Norway's largest innovation festival spanning a full week with 100+ events across Oslo, organized by Innovation Norway and the City of Oslo. Covers cleantech, ocean tech, healthtech, and fintech with 10,000+ participants. Most events are free or low-cost, making it highly accessible.
Oura is a Finnish wearable company best known for the Oura Ring, a smart ring that packages continuous biometric sensing into a minimal consumer device. The product built its reputation through strong sleep and recovery tracking, then expanded into broader health insights around readiness, activity, stress, and women's health. What makes Oura significant in the European ecosystem is its ability to combine hardware design, sensor engineering, mobile product experience, and recurring software engagement into a durable health platform. Many consumer wearables compete on notifications and surface-level metrics; Oura instead positioned itself around insight quality, habit formation, and long-term user retention. That has made it a standout European example of a hardware-plus-subscription business that can scale globally without losing product clarity. In directory terms, Oura also broadens the map between consumer technology and healthtech, showing how European startups can build defensible products at the intersection of devices, data, and preventive care. Its success offers a useful contrast to pure software companies and highlights Finland's continued ability to produce globally relevant product and hardware talent.
Oviva is a digital health company that helps people with weight-related and metabolic conditions, including obesity, type 2 diabetes, prediabetes, and hypertension, improve their health through medical nutritional therapy. Its model combines a medical-device-certified smartphone app with clinical teams of doctors, dietitians, and behavioural specialists, with patients logging meals, activity, and weight while receiving tailored remote support from their dietitian. The company describes itself as Europe's leading digital health provider for weight-related conditions, with care reimbursed as a certified DiGA in Germany, delivered in partnership with the NHS in the UK, and integrated into Swiss public healthcare. It is headquartered in Zurich.
Founded in 2015, Panakes Partners is a Milan-based healthcare VC investing EUR 1-8M at Series A and B in medical devices, diagnostics, digital health, and biotech across Europe. The firm manages over EUR 100M and focuses on companies with clear clinical evidence and regulatory pathways. Portfolio includes MMI (surgical robotics, IPO on Euronext), Novavido, and Kither Biotech. The team of medtech executives and clinicians provides hands-on support in clinical trials, CE marking, and commercialization.
Berlin-based healthtech company offering an emergency smartwatch paired with a companion app for elderly people living independently. The SIM-enabled device connects to a 24/7 emergency call centre at the press of a button and keeps family members informed. Serves 25,000 users and has handled over 500,000 emergency calls.
Curated startup and investor conference at Habakuk Congress Centre, capped around 1,200 attendees for deal quality. Known for selected startup participation, Podim Pitching Competition, and structured 1:1 meetings.
International healthtech and biotech conference hosted by Łukasiewicz – PORT, focused on cancer research, diagnostics, and therapy. Relevant for healthtech and biotech founders and researchers seeking R&D partners, clinical collaborators, and exposure to the Łukasiewicz innovation network.
PortfoLion is the venture capital and growth equity arm of OTP Bank, Hungary's largest bank, managing approximately €440 million in AUM across three distinct funds targeting seed, growth, and turnaround stages. Founded in 2010 and headquartered in Budapest, it is the most prominent institutional VC in the CEE region by assets under management, with 64 portfolio companies across Hungary and wider Central and Eastern Europe. Its seed fund deploys €500k–€3 million per ticket and the growth fund €5–30 million, with notable investments including SEON (which went on to raise $150 million from Creandum and IVP) and Tresorit (acquired by Swiss Post). The firm has a team of 33 professionals including five partners.
Powerful Medical builds clinical-grade AI for cardiology. Its flagship product, PMcardio, can diagnose acute heart attacks by analyzing a photo of a 12-lead ECG, outperforming average human interpretation in critical scenarios. The system is FDA and MDR certified and is being rolled out in hospitals across Europe and the UK. By 2026, Powerful Medical is one of the region’s most credible medical AI companies with global regulatory traction.
Predicting Health develops AI-based clinical risk prediction tools that analyze patient data to support early intervention and improve care quality. The company is a spin-off from the KAGes Data Science Team in Graz and operates in the same category as platforms like PIPRA.
Founder of Grupa Pracuj and investor associated with Market One Capital (MOC), Przemysław focuses on marketplace models and network-effect businesses. He invests both personally and through fund activity, bringing strategic support in category creation, scaling, and international expansion. Notable portfolio references include Tier Mobility, Packhelp, and DocPlanner.
Founder of InPost and one of Poland’s highest-profile entrepreneurs, Rafał is active as an impact-oriented investor through personal and foundation initiatives. His flagship company reached a landmark Amsterdam IPO, and his broader investment activity spans logistics-adjacent consumer sectors, food, and medical innovation. Notable references include activity around Bakalland and support for oncology and advanced medical equipment initiatives.
HealthTech company offering a CE-certified at-home finger-prick blood collection kit and digital platform; samples ship to partner labs and users get lab-grade results for 30+ tests within 24 hours.
Develops grain-of-rice-sized microrobots designed to navigate inside the human brain to deliver therapeutic molecules, implant electrodes or collect cellular data, aiming to make neurosurgery safer and more precise for conditions including glioblastoma.
Founder of Polish Angels and managing partner at COBIN Angels, Robert is a veteran executive with experience at Xerox, HP, and Atos. He serves as a board member of the European Business Angels Network (EBAN) and specializes in business strategy and transaction structuring for early-stage deals. Notable involvements include CliniNote (AI-powered healthtech platform, co-founder), board roles with Photon Entertainment, Salesbook, and Vindicat, plus prior supervisory board service at Work Service S.A.
SABAH.HUB is a private innovation center and accelerator founded in 2021 that supports startups at pre-seed and seed stages. It offers incubation, acceleration, and education tracks (SABAH.academy, SABAH.incubation, SABAH.lab) and has made 16 investments in its portfolio. It co-organizes the Baku Investment Day (Baku ID) conference in partnership with the World Economic Forum's Centre for the Fourth Industrial Revolution Network.
SagaNatura is a Hafnarfjörður-based Icelandic biotech company producing premium natural ingredients from Iceland's pristine environment, including high-purity natural astaxanthin from microalgae and wild-grown organic Angelica Archangelica. The company traces its roots to SagaMedica (founded 2000) and KeyNatura (founded 2014), which merged to form the current entity. SagaNatura supplies nutraceutical ingredients to markets in North America and Asia-Pacific, and operates a consumer brand, KeyNatura, sold direct-to-consumer and through distributors worldwide. The company was tracking EUR 23 million in annual sales by 2025 and had been eyeing a potential IPO.
Major French healthcare and hospital innovation expo with a large innovation village for digital health ventures. High-value event for founders targeting public-hospital procurement and clinical pilot partnerships.
Clinical platform and EHR for outpatient and private healthcare providers, connecting scheduling, billing, telehealth and patient records in one system. Serves 1,700 customers including Nuffield Health; 10M+ UK patients have been seen by a clinician using it.
Sidekick Health is a Reykjavik- and Boston-based digital therapeutics company that builds disease-specific care programs delivered through a mobile app, combining behavior-change design, gamification, AI-driven personalization, and clinician oversight to help patients manage chronic conditions such as type 2 diabetes, obesity, cardiovascular risk, and certain cancers. Its programs are sold primarily to pharma companies, payers, and health systems that wrap them around drug therapy or chronic-care pathways, and the company has signed deals with several top-20 pharmaceutical manufacturers to run companion digital programs in multiple therapeutic areas. Founded by two Icelandic physicians, Sidekick is one of the most internationally visible examples of Icelandic health-tech, and together with Kerecis it shows that the country's life-sciences output extends from physical regenerative materials into software-as-medicine.
Free week-long festival at the Stavros Niarchos Foundation Cultural Center, with the SNF Nostos Conference (June 22-26) bringing international speakers on health, education, climate and the future of society alongside concerts and interactive programming.
A former Spotify executive turned prominent angel (and VC at Atomico), Sophia from Sweden has invested in Polish startups, particularly in fintech and healthtech. She was an early angel in Warsaw-based Doctorly and supports female-founded companies in Poland through programs like Lift Women. Associated startups: Doctorly, Village Network (and other Polish startups via Atomico Angel Programme).
SOPHiA GENETICS is a Lausanne-based health-tech company founded in 2011 by Jurgi Camblong and Pierre Hutter as an EPFL spin-out. The company built a clinical AI platform — SOPHiA DDM — that enables hospital and laboratory networks to decode genomic data for oncology, rare disease, and pharmacogenomics applications. Its platform standardises and accelerates genomic analysis across a federated network of more than 780 healthcare institutions in 70 countries, turning each new clinical dataset into a contribution to a collectively smarter system. SOPHiA GENETICS listed on Nasdaq in July 2021, raising $228M, and is backed by Salesforce Ventures and Generation Investment Management. The company represents the EPFL ecosystem's capacity to produce globally significant clinical technology at scale.
Co-founder and CEO of Doctolib, the e-health booking and software platform he started in 2013. He scaled it into one of Europe's most valuable health-tech companies, serving hundreds of thousands of practitioners.
Connected smart stethoscope and AI platform that records and analyses lung and heart sounds for home-based respiratory diagnostics, paediatrics, and remote triage. Combines a CE-marked medical device with cloud-based AI that flags abnormal sounds for physicians. Backed by Movens Capital.
Organizer of digital health matchmaking events for Swedish innovation networks, bridging healthtech startups with hospitals, research institutions, and public sector buyers. Sweden Innovation X facilitates structured meetings and demo days, helping medtech and digital health founders validate solutions and secure pilot partnerships within Sweden's healthcare system.
The leading conference of the Swiss medical technology industry, organized by Swiss Medtech at Kursaal Bern. Attracts 800+ industry representatives annually with the 2026 edition focusing on integration under the multi-year theme 'Mastering Complexity'.
A high-level partnering and investor conference connecting life-science innovators, investors, and industry across Switzerland, Austria, and the Nordics. For a biotech or healthtech founder it provides structured 1-to-1 partnering meetings with investors and pharma in a focused single-day format.
Talkie.ai is a Polish conversational AI platform focused on healthcare voice automation for hospitals, clinics, and medical contact centers. The product handles appointment workflows, prescription-related requests, triage-first routing, and self-service call handling through localized NLP and no-code configuration. Built in Poland with expansion across Europe and the US, it targets high-volume patient communication with compliance-oriented integrations.
Stockholm-based AI medical scribe that listens to doctor-patient consultations and generates structured clinical notes in real time, reducing physician documentation time by up to 70%. Raised a $50M Series A led by Kinnevik in 2026.
Large interdisciplinary tech festival at Funkhaus Berlin combining AI, synthetic biology, Web3, and health tech with music, art, and science programming. Includes startup visibility opportunities and a headline startup pitch competition.
Nordic/Baltic scale-up conference at Friends Arena with 7,500+ attendees and 400+ investors. Known for stage-specific pitch competitions and a strong sustainability and ESG focus.
Norway Health Tech's flagship gathering, expanding to Stavanger at HelseCampus, focused on health system efficiency and health technology for preparedness, defence, and dual use.
AI-powered speech therapy platform for children that diagnoses speech impediments, recommends personalised therapy and delivers 2,000+ exercises as mobile games. Backed by Simpact Ventures and SMOK Ventures.
Managing partner at MCI Capital (Internet Ventures), Tomasz is one of the most experienced digital growth investors in Central Europe. His background includes strategy and international operating exposure, and he has led investments across e-commerce, digital health, and online marketplaces. Portfolio and exit references include Frisco.pl, SiDLY, and Morele.net.
Trondheim Tech Port is Norway's leading technology cluster organization, positioning Trondheim as the country's technology capital. The non-profit interest organization brings together over 100 member companies, universities, research institutions, and public bodies to drive innovation across four strategic sectors: ocean and maritime technology, healthcare, energy, and digitalization. It hosts major annual events including the Bridging the Gap conference and the Trondheim Tech Festival, and counts NTNU, SINTEF, Equinor, and several investment organizations among its members and partners.
UniLab is Latvia's university-backed startup accelerator, jointly run by Riga Technical University, the University of Latvia, Riga Stradinš University, and the Latvia University of Life Sciences and Technologies. Its programmes include UniLab Elevate (incubation for technology-based university spinouts), Venture Catalysts (a commercialisation course for scientists), and UniLab Defence (co-led with NATO DIANA). Active since 2020, UniLab has supported more than 53 emerging startups with personalised mentoring and financial grants.
A €18M debut seed-stage venture fund launched in 2025 and backed by the Polish Development Fund, focused on B2B software, AI and techbio. Co-founded by Aleksandra Pedraszewska (an early ElevenLabs employee), Karolina Kukielka and Zuzanna Brzosko, it invests €500K–€750K in Polish founders building globally.
Venture to Future Fund (VFF) is a state-backed venture capital fund established in 2019 through a joint initiative of the European Investment Bank, the Slovak Ministry of Finance, and Slovak Investment Holding. It launched investments in June 2020 with an initial €40.4 million mandate, subsequently expanded by €15.3 million from the Slovak Recovery and Resilience Plan in 2024, extending its investment period through 2026. VFF focuses exclusively on Slovak innovative SMEs and EU companies with capital ties to Slovakia, deploying €400,000–€7 million per company. Since inception it has backed 16 companies including Photoneo, Sensoneo, Fuergy, and Powerful Medical.
Vigo Health is a digital therapeutics company that developed the Vigo app, an evidence-based, CE-marked rehabilitation tool for stroke survivors combining physiotherapy, cognitive exercises, and patient education. Founded in 2018 by healthcare innovator Kristaps Krafte and neurosurgeon Jānis Šlēziņš, Vigo became the first digital therapeutic in the Baltic states to receive a state reimbursement code from the Latvian National Health Service in 2021. The app is available for home use 24/7 via iPad.
Berlin-based AI companion for nurses and care workers that listens as staff speak care notes aloud and instantly converts speech into structured EHR records, giving clinicians back up to 30% of their shift. Deployed at 1,500+ care facilities across Germany serving 100,000+ nurses. Raised €43M Series A led by Balderton Capital.
Biopharma R&D company using AI-driven protein engineering and wet-lab directed evolution to design highly selective miniprotein therapeutics targeting disease mechanisms resistant to small molecules and antibodies.
Founded 2001. Multi-sector accelerator helping early-stage tech startups reach first customers and EUR 1M ARR within 3 years. KPI-driven programs, zero-equity loans, and coaching; portfolio has 50+ exits. Scope: Regional (Ile-de-France).
Flagship antibody-drug conjugate summit in London bringing together biopharma leaders, biotech investors, and clinical researchers. Covers next-generation ADC design, payload innovation, and clinical trial data from leading oncology programs. Valuable for biotech startups developing targeted therapies and seeking licensing or co-development partnerships.
Large-scale AI conference at the Palais des Festivals with 10,000+ attendees, 320 speakers, and 220+ exhibitors expected for 2026. Program tracks include AI for Business, AI Governance, and Health AI, making it a high-value venue for founders seeking enterprise pilots and investor visibility.